Treatment of apolipoprotein-a1 related diseases by...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/63 (2006.01) A61K 48/00 (2006.01) C12N 15/11 (2006.01) C12N 15/12 (2006.01)

Patent

CA 2739464

Oligonucleotide compounds modulate expression and/or function of an apolipoprotein (ApoA1) polynucleotides and encoded products thereof. Methods for treating diseases associated with apolipoprotein- A1 (ApoA1) comprise administering one or more Oligonucleotide compounds designed to inhibit the Apo-A1 natural antisense transcript to patients.

L'invention concerne des composés d'oligonucléotides qui modulent l'expression et/ou la fonction de polynucléotides d'une apolipoprotéine (ApoA1) et des produits codés de ceux-ci; des méthodes de traitement de maladies liées à l'apolipoprotéine Al (ApoA1), qui comprennent l'administration à des patients d'un ou de plusieurs composés d'oligonucléotides conçus pour inhiber le produit de la transcription de l'ApoA1 antisens naturel.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of apolipoprotein-a1 related diseases by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of apolipoprotein-a1 related diseases by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of apolipoprotein-a1 related diseases by... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1504469

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.